Initial validation of the clinical significance of the NETest in Japanese gastroenteropancreatic neuroendocrine tumor patients-Reference-Cited by-同舟云学术

Initial validation of the clinical significance of the NETest in Japanese gastroenteropancreatic neuroendocrine tumor patients

Published:2024 Issue:9 Volume:71 Page:873-880
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Zhang Hao¹,Tsuchikawa Takahiro²,Takeuchi Satoshi³,Hirata Kenji⁴,Tanaka Kimitaka²,Matsui Aya²,Nakanishi Yoshitsugu²,Asano Toshimichi²,Noji Takehiro²,Nakamura Toru²,Takeuchi Shintaro²,Wada Masataka²,Hirano Satoshi²

Affiliation:

1. Department of Hepatobiliary and Pancreatic Surgery, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China

2. Department of Gastroenterological Surgery II, Hokkaido University Faculty of Medicine, Sapporo 060-8638, Japan

3. Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan

4. Department of Diagnostic Imaging, Graduate School of Medicine, Hokkaido University, Sapporo 060-8638, Japan

Publisher

Japan Endocrine Society

Link

https://www.jstage.jst.go.jp/article/endocrj/71/9/71_EJ24-0090/_pdf

Reference20 articles.

1. 1 Liu M, Li N, Tang H, Chen L, Liu X, et al. (2023) The mutational, prognostic, and therapeutic landscape of neuroendocrine neoplasms. Oncologist 28: e723–e736.

2. 2 Kečkéš Š, Palaj J, Waczulíková I, Dyttert D, Mojtová E, et al. (2021) Pretreatment levels of chromogranin A and neuron-specific enolase in patients with gastroenteropancreatic neuroendocrine neoplasia. In Vivo 35: 2863–2868.

3. 3 van Adrichem RC, Kamp K, Vandamme T, Peeters M, Feelders RA, et al. (2016) Serum neuron-specific enolase level is an independent predictor of overall survival in patients with gastroenteropancreatic neuroendocrine tumors. Ann Oncol 27: 746–747.

4. 4 Corsello A, Di Filippo L, Massironi S, Sileo F, Dolcetta Capuzzo A, et al. (2018) Vasostatin-1: a novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms. PLoS ONE 13: e0196858.

5. 5 Modlin IM, Kidd M, Bodei L, Drozdov I, Aslanian H (2015) The clinical utility of a novel blood-based multi-transcriptome assay for the diagnosis of neuroendocrine tumors of the gastrointestinal tract. Am J Gastroenterol 110: 1223–1232.